- $442.24m
- $400.55m
- $193.40m
- 47
- 22
- 31
- 25
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 90.5 | 104 | 141 | 163 | 193 |
Cost of Revenue | |||||
Gross Profit | 59.6 | 69.1 | 94 | 113 | 136 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 111 | 122 | 230 | 253 | 251 |
Operating Profit | -20.5 | -17.9 | -89.3 | -90.8 | -57.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -22.4 | -24.7 | -30.6 | -63.9 | -67.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -22.4 | -24.7 | -30.7 | -63.9 | -67.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -22.4 | -24.7 | -27.3 | -35.4 | -40.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23 | -244 | -3.78 | -35.4 | -40.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.269 | -2.86 | -0.106 | -0.412 | -0.387 |